Our CEO, Michael "Mick" Farrell, recently spoke with ABC News Australia to share some compelling insights: People prescribed GLP-1 and PAP therapy have 10.8 absolute percentage points more likelihood or propensity to commence positive airway pressure therapy. This breakthrough underscores the important connection between innovative treatments and better adherence to sleep therapy. Watch the video in this article to learn more about ResMed’s growth potential as we continue our mission to create life changing health technologies that people love. https://lnkd.in/eCUdmiPe #ResMed #GLP1 #SleepHealth #CPAPtherapy
ResMed
Productie medische apparatuur
San Diego, CA 198.122 volgers
Pioneering innovative medical device and digital health solutions that treat and keep people out of the hospital.
Over ons
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
- Website
-
https://www.resmed.com
Externe link voor ResMed
- Branche
- Productie medische apparatuur
- Bedrijfsgrootte
- 5.001 - 10.000 medewerkers
- Hoofdkantoor
- San Diego, CA
- Type
- Naamloze vennootschap
- Opgericht
- 1989
- Specialismen
- Sleep apnea, COPD, Out-of-hospital care, Home medical equipment, durable medical equipment, SaaS, CPAP, remote monitoring, patient engagement, Sleep, Respiratory care, medical devices, health IT, digital health, medical software, portable oxygen, ventilation, interoperability en medical technology
Locaties
Medewerkers van ResMed
-
Urvashi Tyagi
Chief Technology Officer | Former CTO of ResMed and ADP. Ex Amex, Amazon, Microsoft, IBM
-
Jeff Haley
-
Grant Olsen
VP Corporate Development, Business Development and Ventures @ ResMed
-
Joseph Caudill
Associate Director of Software Engineering at MatrixCare (a ResMed Company)
Updates
-
At ResMed, we proudly stand with the American Academy of Sleep Medicine (AASM) in advocating for permanent coverage and adequate reimbursement for telehealth services. With Congress considering an extension of telehealth flexibilities expiring on December 31, 2024, the time to act is now. These flexibilities have expanded the range of telehealth services available to Medicare beneficiaries, making a meaningful difference in healthcare delivery. As a leader in sleep health, ResMed is committed to driving this extension forward to ensure continued progress in care accessibility and quality. Why Telehealth is Critical for Sleep Medicine: ✅ Access: Reaching patients in areas with limited provider availability. ✅ Efficiency & Safety: Enhancing clinician workflows and prioritizing patient safety. ✅ Health Equity: Bridging gaps in underserved communities. ✅ Treatment Adherence: Leveraging remote monitoring to improve outcomes in conditions like CBT-I and OSA. Telehealth isn’t just a convenience—it’s a catalyst for delivering high-quality, patient-centered sleep care. To secure its future, we call on legislators, policymakers, clinicians, and patients to work together and advocate for the permanent adoption of telehealth solutions. Together, we can ensure that telehealth remains a cornerstone of accessible, effective, and equitable sleep care for all. #Telehealth #SleepHealth #HealthEquity #HealthcareInnovation #AASM #ResMed https://lnkd.in/gRXbfmG7
Recommendations for permanent sleep telehealth: an American Academy of Sleep Medicine position statement | Journal of Clinical Sleep Medicine
jcsm.aasm.org
-
ResMed heeft dit gerepost
Over the last 35 years, our team has constantly pushed the innovation boundaries to create life-changing health technologies that people love. With our deep knowledge of engineering head-worn products, we are excited to bring our expertise in designing lightweight and comfortable headgear and facial interfaces to the Apple Vision Pro community with the Kontor Head Strap. Introducing the Kontor Head Strap, a new accessory for #AppleVisionPro that delivers the perfect balance of softness and support for extended wear-time. Learn more: https://lnkd.in/gnjmXSRh
-
We're elevating immersive experiences for Apple Vision Pro users with the Kontor Head Strap! With over 35 years of expertise in designing headgear and facial interfaces, we're committed to developing technology that people love, and we look forward to bringing that expertise to the Apple Vision Pro community with the Kontor Head Strap. Learn more about the Kontor Head Strap: https://lnkd.in/eSv8bCCw
-
We're excited to share that our ResMed Sustainability Report is now available! In this report, we provide an update on our ongoing journey toward sustainability, reflecting our commitment to creating positive impact. Sustainability has been an important focus at ResMed, and we continue to prioritize the health and well-being of our people, the planet, and the communities where we live and work. Learn more about our Sustainability journey here: 🔗 https://lnkd.in/e3xXkNRN #Sustainability #CorporateSocialResponsibility #Ethics #Compliance #CSR
-
ResMed heeft dit gerepost
My Watch Just Told Me I Might Have Sleep Apnea: Sleep Health and the Role of Consumer Tech
My Watch Just Told Me I Might Have Sleep Apnea
Carlos Nunez op LinkedIn
-
As a "Best Place to Work for Disability Inclusion" by Disability:IN, we are committed to building an inclusive culture and ensuring inclusive design and accessibility in our testing and products. In honor of International Day of Persons with Disabilities, ResMed held a session on 'Disability Inclusion in the Workplace' to better understand how to cultivate an inclusive and safe environment for everyone, where employees learned about the etiquette of working with people of all abilities and across neurodiversity. Conversations like these help us reflect and take action toward making our company and products more inclusive for everyone. #disabilityinclusion #inclusionworks #disabilityIN
-
ResMed is honored to be named on the 2025 Forbes Most Trusted Companies list!! This special recognition reflects ResMed's commitment to improving lives with innovative solutions and building trust with our customers, employees, and communities. Thank you for believing in us—we couldn’t have done it without you! Learn more about the list here: https://lnkd.in/g_Dtivsy
Forbes Most Trusted Companies in America 2025 List
social-www.forbes.com
-
“Anyone can have sleep apnoea, some people think you have to be overweight but it's not true - weight is an issue but it's not the whole story." Meet Anya, a dedicated mom who discovered she had been living with #SleepApnea for over two decades. Thanks to CPAP therapy, she's finally getting the restful sleep she deserves. Spread awareness about the life-changing effects of quality sleep and share your story with #PAPSavedMyLife. This testimonial is a genuine and documented account of the individual’s response to treatment. Outcomes and results may vary, and this individual’s response does not provide any indication, warranty or guarantee that other people will have the same or a similar experience. Talk to your healthcare professional for further information. ALWAYS READ THE LABEL AND FOLLOW THE INSTRUCTIONS FOR USE. IF SYMPTOMS PERSIST, TALK TO YOUR HEALTHCARE PROFESSIONAL.
-
How do people feel about the new ResMed AirTouch N30i? “The most comfortable mask I’ve ever tried.” -AirTouch N30i user Read more about our AirTouch N30i mask here: www.resmed.com/HighRes #sleephealth #CPAP #AirTouchN30i #ResMed
Gerelateerde pagina’s
Vergelijkbare pagina’s
Door vacatures bladeren
Aandeel
RMD
NYSE
20 minuten vertraging
US$ 237,39
5,81 (2,509%)
- Opening
- 231
- Laag
- 231
- Hoog
- 238,6
Gegevens van Refinitiv
Bekijk meer informatie overFinanciering
Laatste ronde
Schuld na beursgangUS$ 500.000.000,00